Number of Shares
83,925.00
Current Holdings Value*
$3.66 Mil
% of Portfolio
3.82%
Total Estimate Gain
$-357,034.99
% of Total Estimate Gain
-7.28%

Benchmark Capital Advisors's Pfizer Inc Holding Summary

As of 2018-12-31, Benchmark Capital Advisors held 83,925.00 shares of Pfizer Inc(PFE), totaling $3.66 Mil. This investment constitutes 3.82% of their stock portfolio, and Benchmark Capital Advisors now holds 0% of the outstanding Pfizer Inc(PFE) stock.

The initial trade took place in 2013Q4. And since then Benchmark Capital Advisors has made 2 purchases of PFE, at an average price of $31.44, for a total of 155,998.00 shares. In addition, there have been 6 sales at an average price of $33.58 for 72,073.00 shares. Based on historical transaction data and PFE's current price of $25.35, Benchmark Capital Advisors's estimated gain on his PFE holdings is $-357,034.99, reflecting a -7.28% gain to date.

Benchmark Capital Advisors PFE ($25.35) Holding Chart

Benchmark Capital Advisors PFE ($25.35) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1